Emanuelsson B M, Paalzow L K
Department of Biopharmaceutics and Pharmacokinetics, Uppsala University, Sweden.
Biopharm Drug Dispos. 1988 Jan-Feb;9(1):59-70. doi: 10.1002/bod.2510090107.
The basic pharmacokinetics of probenecid was studied by administration of three different i.v. bolus doses (50, 75, and 100 mg kg-1) to rats. The protein binding of probenecid in pooled rat serum was estimated by equilibrium dialysis. The unbound fraction was found to increase non-linearly with increasing total concentration, yielding a maximum free fraction of 49 per cent. The plasma concentration data obtained were described by a two-compartment model with Michaelis-Menten elimination. The maximal rate of elimination (Vm) remained unchanged between different doses irrespective of whether it was calculated in total or free concentrations (mean 187.2 +/- 8.3 (SD) microgram min-1). The Michaelis-Menten constant (Km) decreased slightly with increasing dose, while the unbound Michaelis-Menten constant (Km,u) did not change between the doses (mean 37.1 +/- 1.3 (SD) microgram ml-1). The volume of distribution of the central compartment (Vc) did not alter when the dose was increased from 50 to 100 mg kg-1 (mean 56.5 +/- 4.3 (SD) ml), but the unbound volume of distribution of the central compartment (Vc,u) decreased from 186.5 +/- 15.6 (SD) to 89.8 +/- 6.9 (SD) ml, which is in accordance with the reduction to be expected for drugs that only distribute in the extracellular fluid.
通过给大鼠静脉注射三种不同剂量(50、75和100 mg kg-1)的丙磺舒来研究其基本药代动力学。采用平衡透析法测定丙磺舒在大鼠混合血清中的蛋白结合率。发现游离分数随总浓度增加呈非线性增加,最大游离分数为49%。所获得的血浆浓度数据用具有米氏消除的二室模型描述。不同剂量之间最大消除速率(Vm)保持不变,无论按总浓度还是游离浓度计算(平均187.2±8.3(SD)μg min-1)。米氏常数(Km)随剂量增加略有下降,而游离米氏常数(Km,u)在各剂量之间无变化(平均37.1±1.3(SD)μg ml-1)。当剂量从50 mg kg-1增加到100 mg kg-1时,中央室分布容积(Vc)未改变(平均56.5±4.3(SD)ml),但中央室游离分布容积(Vc,u)从186.5±15.6(SD)ml降至89.8±6.9(SD)ml,这与仅分布于细胞外液的药物预期的减少情况相符。